Key information is needed for excipients and their potential impact on continuous manufacturing processes.
Joseph Zeleznik
Advertisement
Joseph Zeleznik is technical product director, IMCD US
Articles by Joseph Zeleznik
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsPublished: February 3rd 2021 | Updated:
Understanding Excipient Characteristics to Ensure Robust Continuous ManufacturingPublished: June 13th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
